文献速递结核与非结核分枝杆菌真菌感染

肺结核治疗患者中慢性肺曲霉病的系统综述

A Systematic Review of Chronic Pulmonary Aspergillosis Among Patients Treated for Pulmonary Tuberculosis.
PubMed 文献 · Clin Infect Dis · 2025-01-01

该系统综述检索多个数据库至2025年1月10日,纳入22项队列和横断面研究共2884例结核患者。Meta分析显示,所有结核患者中治疗期间慢性肺曲霉病患病率为9%(95%CI 6%-12%),治疗后为13%(95%CI 6%-27%);持续呼吸道症状者治疗期间为20%,治疗后为48%(95%CI 36%-61%)。症状状态和评估时机是显著预测因素。

要点

  • 所有结核患者中,治疗期间慢性肺曲霉病患病率为9%(95%CI 6%-12%),治疗后为13%(95%CI 6%-27%)。
  • 持续呼吸道症状者中,治疗期间患病率为20%,治疗后为48%(95%CI 36%-61%)。
  • 症状状态和慢性肺曲霉病评估时机是患病率的显著预测因素。

核心结论

  • 结核幸存者中慢性肺曲霉病负担高,尤其持续症状者,需在结核规划中常规筛查慢性肺曲霉病。

研究设计与样本

  • 系统检索PubMed、Cochrane Library、Web of Science和Science Direct至2025年1月10日,纳入22项队列和横断面研究共2884例患者。
  • 三名评价者筛选1575项唯一研究,评估118篇全文,纳入22项研究。
  • 采用随机效应模型进行Meta分析,通过亚组分析和Meta回归探索影响因素。

主要发现

  • 所有结核患者中,治疗期间慢性肺曲霉病患病率为9%(95%CI 6%-12%),治疗后为13%(95%CI 6%-27%)。
  • 持续呼吸道症状患者中,治疗期间慢性肺曲霉病患病率为20%,治疗后为48%(95%CI 36%-61%)。
  • Meta回归确定症状状态和慢性肺曲霉病评估时机为患病率的显著预测因素。

临床怎么用

  • 作者认为结核幸存者中慢性肺曲霉病负担高,尤其持续症状者,需在结核规划中常规筛查慢性肺曲霉病,早期发现和靶向干预可减少呼吸系统并发症并改善患者结局。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Tuberculosis (TB) is a major global health concern, with long-term complications persisting even after successful treatment. Chronic pulmonary aspergillosis (CPA) is a progressive fungal disease that frequently develops in TB survivors, contributing to post-TB lung disease. The true burden of CPA among patients with TB remains unclear due to diagnostic challenges and limited data. We aimed to estimate the prevalence of CPA among patients with prior or concurrent TB. METHODS: We conducted a systematic search in PubMed, Cochrane Library, Web of Science, and Science Direct through 10 January 2025. Eligible cohort and cross-sectional studies reported CPA prevalence in patients diagnosed with TB based on clinical symptoms, radiographic abnormalities, and microbiological evidence. Three reviewers screened 1575 unique studies, assessed 118 full texts, and included 22 studies (2884 patients). We conducted a meta-analysis using a random-effects model to estimate pooled CPA prevalence, with subgroup and meta-regression analyses exploring factors influencing CPA burden. RESULTS: CPA prevalence varied by timing of assessment and symptom status. Among all patients with TB, CPA prevalence was 9% (95% confidence interval [CI]: 6%-12%) during treatment and 13% (95% CI: 6%-27%) posttreatment. Among patients with persistent respiratory symptoms, CPA prevalence was 20% during treatment and 48% (95% CI: 36%-61%) posttreatment. Meta-regression identified symptom status and timing of CPA assessment as significant predictors of CPA prevalence. CONCLUSIONS: The high CPA burden among TB survivors, particularly those with persistent symptoms, underscores the need for routine CPA screening in TB programs. Early detection and targeted interventions could reduce respiratory complications and improve patient outcomes.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Madden AE, Ofori SK, Budu M, et al. A Systematic Review of Chronic Pulmonary Aspergillosis Among Patients Treated for Pulmonary Tuberculosis. Clin Infect Dis. 2025. PMID: 40117217. doi:10.1093/cid/ciaf150

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。